Budget

President Donald Trump’s proposed budget blueprint calls for industry to double up on user fees to fully pay for FDA premarket approvals in exchange for administrative reforms aimed at speeding products to market.

Non-defense federal agencies will be cut a total of $54 billion as part of President Donald Trump's proposed discretionary budget to offset new military spending the White House said Monday (Feb. 27), a cut if applied equally across agencies could render FDA incapable of fulfilling its responsibilities, a longtime FDA observer told Inside Health Policy.

The Committee for a Responsible Federal Budget says President Donald Trump should propose Medicare and Social Security reforms in his “skinny budget” that is expected soon.

Democrats blasted Republicans over several draft reform bills that would stabilize the marketplace saying the reforms are incomplete and would take the health care system back to the way it was before the Affordable Care Act, especially if Republicans move forward with repealing the health care law.

FDA’s efforts to fill 1,000 vacancies at the agency, boosted by provisions in the 21^st Century Cures Act, could be jeopardized by President-elect Donald Trump’s proposed federal government hiring freeze, warned Steven Grossman, deputy executive director of the Alliance for a Stronger FDA.

The Senate failed Tuesday (Sept. 27) to advance a temporary government spending bill introduced by Senate Majority Leader Mitch McConnell (R-KY) that would fund Zika vaccine development and mosquito control, as well as provide resources for the opioid bill signed into law earlier this year.

House Appropriations health subcommittee Republicans on Thursday (July 7) blocked Democrats’ amendments to restore funding that the chamber's HHS-spending bill would eliminate, such as money for Obamacare programs, comparative-effectiveness research and family planning programs.

Six former FDA commissioners over the weekend expressed support for making the FDA an independent agency, citing concerns with accessibility to the president, the affects of micromanagement on the agency and the “political maze” regulatory decisions currently need to navigate that keep FDA from taking important actions.

Senators may offer provisions of the Senate's version of the 21st Century Cures Act to the National Defense Authorization Act and the agriculture appropriations bill, a congressional aide told Inside Health Policy.